KCNQ2 and epilepsy: Recent work has shown that KCNQ3 dysfunction leads to pharmaco-dependent epilepsy in patients lacking both functional Kcnq3 copies (Lauritano et al., 2019), which is distinct from the pharmaco-resistant epilepsy caused by KCNQ2 dominant-negative variants (Cornet et al., 2018).